MANAGEMENT OF NEUROLOGICAL TOXICITIES OF PATIENTS TREATED WITH IMMUNOTHERAPIES FOR MULTIPLE MYELOMA: A SINGLE-CENTER REAL WORLD EXPERIENCE2026-04-010 PRE AI MManzato, E. PPuppi, M. TTalarico, M. IIezza, M. MMasci, S. GGhibellini, S. VVitale, A. TTacchetti, P. MMancuso, K. ZZamagni, E. DOI:OriginalOriginal request for helpShareSaveAbstract En